Breast: Page 325

GE event includes portable mammo launch
By AuntMinnie.com staff writers
GE Healthcare introduced an ultraportable mammography system called SenoCase that's the size of a large suitcase at its September 15 media event in New York City.
September 15, 2011
GE event assembles investors, advocates to fight cancer
By Cynthia E. Keen
NEW YORK CITY - GE Healthcare today upped the ante in its war on cancer, assembling a star-studded field of public health advocates and venture capitalists to announce a new round of investments to accelerate innovation in cancer detection and therapy.
September 14, 2011
Novarad nets Calif. NovaMG contracts
By AuntMinnie.com staff writers
RIS and PACS vendor Novarad said it has won two mammography contracts in California for its NovaMG breast imaging viewer.
September 14, 2011
GE to invest $1B in new oncology R&D
By AuntMinnie.com staff writers
GE Healthcare has announced plans to dedicate $1 billion of its total R&D budget over the next five years to expand its advanced cancer diagnostic and molecular imaging offerings, as well as technologies for manufacturing biopharmaceuticals and for cancer research.
September 14, 2011
Breast density bill passes in Calif.
By AuntMinnie.com staff writers
California's state Legislature has passed a bill that requires women with dense breast tissue to be informed of their status, according to its sponsor, Sen. Joe Simitian. The bill now goes to Gov. Jerry Brown for consideration.
September 13, 2011
Esaote releases ElaXto elastography
By AuntMinnie.com staff writers
Ultrasound vendor Esaote North America has released its new elastography application, ElaXto, for the company's new ultrasound scanners, MyLabTwice and MyLabClassC.
September 13, 2011
ASCO: PET/CT helps predict metastatic breast cancer outcome
By Kate Madden Yee
Maximum standardized uptake values on PET/CT scans can help predict prognosis in breast cancer patients with bone metastases, but other PET/CT values could be even more useful, according to research presented last week at the American Society of Clinical Oncology (ASCO) Breast Cancer Symposium.
September 13, 2011
FDA gets an earful on mobile apps; ASCO study casts doubt on mammo screening
By Brian Casey
September 12, 2011
Fuji's Aspire HD flat-panel FFDM nets FDA OK
By AuntMinnie.com staff writers
Fujifilm Medical Systems USA has received 510(k) clearance from the U.S. Food and Drug Administration for its Aspire HD flat-panel full-field digital mammography (FFDM) system.
September 11, 2011
Women with BRCA genes getting diagnosed earlier
By Kate Madden Yee
Women who carry BRCA1 or BRCA2 genes are diagnosed with breast cancer almost eight years earlier than relatives in the previous generation who also had the disease and/or ovarian cancer, according to new research from MD Anderson Cancer Center published online September 12 in Cancer.
September 11, 2011
ASCO: Mortality decline in Sweden not due to mammo screening
By Kate Madden Yee
SAN FRANCISCO - Regular mammography screening was not an important factor behind a 14% reduction of breast cancer mortality in Sweden starting in the 1980s, according to data presented on September 8 at the American Society of Clinical Oncology (ASCO) Breast Cancer Symposium.
September 8, 2011
ASCO: Study finds breast self-exams, annual screening key
By Kate Madden Yee
Mammography and breast self-exams remain important tools for detecting breast cancer, even among women ages 40 to 49, according to a study to be presented this week at the American Society of Clinical Oncology (ASCO) Breast Cancer Symposium in San Francisco.
September 6, 2011
Previous Page
Page 325 of 579
Next Page